ClinicalTrials.Veeva

Menu

Prognosis of Acute Kidney Injury:China Collaborative Study on AKI(CCS-AKI)Study

X

XinLing Liang

Status

Enrolling

Conditions

Acute Kidney Injury

Study type

Observational

Funder types

Other

Identifiers

NCT03061786
CCS-AKI P2011-2016

Details and patient eligibility

About

Acute kidney injury (AKI) is a common clinical syndrome, especially in the hospital patients. AKI is recognized as an important risk factor for incident chronic kidney disease, accelerated progression to end-stage renal disease,and increased risk of short-term and long-term mortality.This study is to observe the prognosis of hospitalized patients with AKI in China.

Enrollment

1,000,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • clinically diagnosed with acute kidney injury, according to KDIGO criteria

Exclusion criteria

  • Nephrectomy
  • Kidney transplantation
  • Peak serum creatinine of less than 53µ mol/L
  • Serum creatinine decrease after amputation
  • Patients died during hospitalization
  • End-stage kidney disease(chronic kidney disease stage 5)
  • malnutrition

Trial design

1,000,000 participants in 2 patient groups

AKI
non-AKI

Trial contacts and locations

1

Loading...

Central trial contact

Liang Xinling, MD,PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems